Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

Often called a “silent killer,” symptoms of pancreatic cancer rarely appear until the disease has advanced, limiting ...

Pancreatic cancer develops quietly, with symptoms that may seem insignificant at first glance. This cancer affects the ...

Pancreatic cancer is one of the deadliest cancers, with a five-year survival rate of only seven percent - and with symptoms ...

An analysis of pancreatic cancer data in younger adults found that while there is an increasing incidence of pancreatic cancer in young adults, the mortality rate remains stable.

Ohio State cancer researchers and surgeons are developing and deploying cutting-edge techniques to help patients.

In a new survey, over half of adults under 50 said they wouldn't recognize the early warning signs of pancreatic cancer—a ...

CD40 agonists have had mixed results in cancer to date, with Roche discontinuing its selicrelumab candidate after ...

Radiation therapy: Radiation therapy is primarily used in advanced cases to reduce pain and provide palliative care, ...

Jason McCarthy, an analyst from Maxim Group, maintained the Buy rating on RenovoRx (RNXT – Research Report). The associated price target ...

A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from ...